NYXH Nyxoah

Information on the total number of voting rights and shares

Information on the total number of voting rights and shares

REGULATED INFORMATION

Mont-Saint-Guibert (Belgium), September 30, 2022, 10:30 pm CET / 4:30 pm ET – In accordance with article  15 of the Law of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels and Nasdaq: NYXH) publishes the belowinformation following the issue of new shares.

  •  Share capital: EUR 4,440,069.16 
  •  Total number of securities carrying voting rights: 25,846,279 (all ordinary shares) 
  •  Total number of voting rights (= denominator): 25,846,279 (all relating to ordinary shares)  
  •  Number of rights to subscribe to securities carrying voting rights not yet issued: 
    •  55 “2016 ESOP Warrants” issued on November 3, 2016, entitling their holders to subscribe to a total number of 27,500 securities carrying voting rights (all ordinary shares); 
    •  100 “2018 ESOP Warrants” issued on December 12, 2018, entitling their holders to subscribe to a total number of 50,000 securities carrying voting rights (all ordinary shares);  
    •  460,500 “2020 ESOP Warrants” issued on February 21, 2020, entitling their holders to subscribe to a total number of 460,500 securities carrying voting rights (all ordinary shares); and
    •  1,378,125 “2021 ESOP Warrants” issued on September 8, 2021, entitling their holders to subscribe to a total number of 1,378,125 securities carrying voting rights (all ordinary shares).  

*

*        *

For further information, please contact:

Nyxoah

Jeremy Feffer, VP IR and Corporate Communications

 

Attachment



EN
30/09/2022

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Nyxoah

 PRESS RELEASE

Nyxoah Announces Issuance of First Tranche of Convertible Bonds

Nyxoah Announces Issuance of First Tranche of Convertible Bonds Nyxoah Announces Issuance of First Tranche of Convertible Bonds Mont-Saint-Guibert, Belgium – December 19, 2025, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA) through neuromodulation, today announced the issuance of the first tranche of the convertible bond financing entered into with an entity managed by Heights Capital Management (“HCM...

 PRESS RELEASE

Nyxoah Annonce L’Émission de la Première Tranche des Obligations Conve...

Nyxoah Annonce L’Émission de la Première Tranche des Obligations Convertibles Nyxoah Annonce L’Émission de la Première Tranche des Obligations Convertibles Mont-Saint-Guibert, Belgique – 19 décembre 2025, 10:05p.m. CET / 4:05p.m. ET – Nyxoah SA (Euronext Brussels/Nasdaq : NYXH) (« Nyxoah » ou la « Société »), une société de technologie médicale spécialisée dans le développement et la commercialisation de solutions innovantes pour le traitement de l'Apnée Obstructive du Sommeil (AOS) par neuromodulation, a annoncé aujourd'hui l’émission de la première tranche du financement par obligations ...

 PRESS RELEASE

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in ...

Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the Netherlands Nyxoah Announces Commercial Launch of Genio® Breakthrough Therapy in the NetherlandsFirst Genio implants successfully performed at OLVG West and Zuyderland hospitals Mont-Saint-Guibert, Belgium – December 17, 2025, 7:05am CET / 1:05am ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” or the “Company”), a medical technology company that develops breakthrough treatment alternatives for Obstructive Sleep Apnea (OSA) through neuromodulation, today announced the commercial launch of its Genio® system i...

 PRESS RELEASE

Nyxoah Annonce le Lancement Commercial de la Thérapie Innovante Genio®...

Nyxoah Annonce le Lancement Commercial de la Thérapie Innovante Genio® Aux Pays-Bas Nyxoah Annonce le Lancement Commercial de la Thérapie Innovante Genio® Aux Pays-BasPremières implantations Genio réalisées avec succès dans les hôpitaux OLVG West et Zuyderland Mont-Saint-Guibert, Belgique – 17 décembre 2025, 7h05 CET / 1h05 ET – Nyxoah SA (Euronext Bruxelles/Nasdaq : NYXH) (« Nyxoah » ou la « Société ») une société de technologie médicale spécialisée dans le développement et la commercialisation de solutions innovantes pour le traitement de l'Apnée Obstructive du Sommeil (« AOS ») par neu...

 PRESS RELEASE

Publication relating to transparency notifications

Publication relating to transparency notifications                  REGULATED INFORMATION Publication relating to transparency notifications Mont-Saint-Guibert (Belgium), December 2, 2025, 10:30 pm CET / 4:30 pm ET – In accordance with article 14 of the Act of 2 May 2007 on the disclosure of large shareholdings, Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) announces that it received two transparency notifications as detailed below. Robert Taub / BMI Estate On November 27, 2025, Nyxoah received a transparency notification from Robert Taub and related person BMI Estate. Based on the notifi...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch